ColiseoHead-to-Head Startup Ranking & Discovery
M
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Founded
2018
Headquarters
Austin, TX, USA
Team size
11–50
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1497 Elo
Total matchups0
⚔️ Vote on today's matchups →Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →